Abstract
Arteriosclerosis is very strongly connected with the aging process. The lots of theories over the last 170 years elucidate two crucial problems of arteriosclerosis research:
-
1.
Arteriosclerosis (AS) is generated by multiple endogenous and exogenous factors influencing differently the progression of the disease.
-
2.
Arteriosclerosis develops very slowly over decades. That means the causing biochemical agents may show only minimal deviations from normal range at any given time of the pathogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Assmann, G., Oberwittler, W., Schulte, H., Schriewer, H., Funke, H., Epping, P.H., Hauss, W.H.: Prädiktion und Früherkennung der koronaren Herzkrankheit — Prospektive epidemiologische Studie bei Betriebsangehörigen im Raum Westfalen. Internist. 1980; 21: 446–459.
Assmann, G.: Lipid metabolism and atherosclerosis. Schattauer Stuttgart, New York 1982.
Assmann, G., Schulte, H.: Prediction and early detection of coronary heart disease. Rhein: Westfäl. Akad. der Wissenschaften. Abhandlung Bd. 70, Westdeutscher Verlag 1983.
Bagdade, J.D.: Hyperlipidemia and atherosclerosis in chronic dialysis patients. In: Drukker, W. et al. (Ed.): Replacement of renal function by dialysis. Martinus Nijhoff Publ. Bosten, Den Haag 1983; II. Edition: 588–594.
Borle, A.B.: Calcium metabolism in hela cells and the effects of parathyreoid hormone. Journal Cell. Biol. 1968; 36: 567–582.
Brunner, F.P., Brynger, H., Chantier, C., Donckerwolcke, RA., Hathway, R.A., Jacobs, C., Selwood, N.H., Wing, A.J.: Combined report on regular dialysis and transplantation in Europe IX, 1978: Proc. EDTA 1979; 16: 2–70.
Cavaliero, C., Di Tondo, U., Mingazzini, P., Pesando, P., Spagnoli, L.: Cell proliferation in the atherosclerotic lesions of cholesterol-fed rabbits. Atherosclerosis 1973; 17: 49–62.
Cheung, J.Y., Bonventre, J.V., Malis, C.D., Leaf, A.: Calcium and ischemic injury. N. Engl. J. Med. 1986; 314: 1670–1676.
with highly potent inhibitory effects on excitation-contractation coupling in mammalian myocardium. Pflügers Arch. Ges. Physiol. 1969; 307: 25.
Fleckenstein, A.: Calcium antagonism: history and prospects for a multifacted pharmacodynamic principle. In: Calcium antagonists and cardiovascular Disease; Opie LH (Ed.), Raven Press. New York 1984; 9–28.
Fleckenstein, A., Frey, M., Zorn, J., Fleckenstein-Grün, G.: Antihypertensive anticalcitonische und antiarteriosklerotische Effekte von Calcium-Antagonisten. Modell-Experimente an spontan-hypertensiven Ratten (SHR). In: Distler A. (Ed.): Calcium-Antagonisten in der Hochdrucktherapie. Schattauer-Verlag Stuttgart, New York 1986; 3–24.
Goldberg, A.P., Harter, H.R., Patsch, W., Schechtman, K.B., Province, M., Weerts, C., Kuisk, I., McCrate, M.: Racial differences in plasma high density lipoproteins in patients receiving hemodialysis. N. Engl. J. Med. 1983; 308: 1245–1252.
Green, D., Stone, N.J., Krumlovsky, F.A.: Putative atherogenic factors in patients with chronic renal failure. Prog. Cardiovasc. Dis. 1983; 26: 133–144.
Grützmacher, P., Radtke, H.W., Schieferdecker, E., Peschke, B., Riepenhausen, J., Fassbinder, W., Schoeppe, W.: Early changes of plasma lipid status and glucose tolerance during the course of chronical renal failure. Contr. Nephrol. 1984; 41: 332–336.
Grützmacher, P.: Is hyperparathyroidism a risk factor for atherosclerosic disease in RDT patients. Nephrol. Dial. Transplant. 1986; 1: 122–123.
Hahn, R., Oette, K., Mondorf, H., Finke, K., Sieberth, H.G.: Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinamias. Atherosclerosis 1983; 48: 279–288.
Hauss, W.H.: Ober Entstehung und Verhütung der Arteriosklerose. Arbeitsgemeinschaft fir Forschung des Landes NRW, Heft N 197: 7–33. Westdeutscher Verlag Köln-Opladen 1970.
Hehrmann, R.: Plasma-Parathormon: Methodik, Pathphysiologie und Klinik. Urban & Schwarzenberg Verlag München—Wien 1980.
Henry, P.D.: Atherosclerosis, calcium and calcium antagonists. Circulation 1985; 72: 456–569.
Henry, P.D., Bentley, K.I.: Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J. Clin. Invest. 1981; 68: 1366–1369.
Hirata, Y., Yoshimi, H., Takata, S., Watanabe, T.X., Kumegai, S., Nakajima, K., Sakakibara, S.: Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1988; 154: 868–875.
Horsch, A., Ritz, E., Heuck, C.C., Hofmann, W., Kühne, E., Bisson, M.: Atherogenesis in experimental uremia. Atherosis 1981; 40: 279–289.
Kai, H., Kanaide, H., Nakamura, M.: Endothelin-sensitive intracellular Ca store overlaps with caffeine-sensitive one in rat aortic smooth muscle cells in primary culture. Biochem. Biophys. Res. Commun. 1989; 158: 235–243.
Karpf, D.B., Bambino, T., Arnaud, D.C., Nissenson, R.A.: Molecular determinants of parathyroid hormone receptor function. In: Cohn, D.V., Charieur, F.H., Martin, T.J. (Ed.): Calcium regulation and bone metabolism, Elsevier Science Publishers 1990.
Krall, E.A., Sahyoun, N., Tannenbaum, S., Dallai, G.E., Dawson-Hughes, B.: Effect of vitamin D intake on seasonal variations in parathyreiod hormone secretion in postmenopausal women. N. Engl. J. Med. 1989; 321: 1777–1783.
Kramsch, D.M., Aspen, A.J., Apstein, C.S.: Suppression of experimental atherosclerosis by the Ca-Antagonist Lanthanum. J. Clin. Invest. 1980; 65: 976–981.
Lichtlen, P.R., Hugenholtz, P.G., Raffenbeul, W., Hecker, H., Jost, S., Deckers, J.W.: Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 1990; 335: 1109–1113.
Lindner, A., Haas, L., Sherrard, DJ.: Atherosclerosis in uremia. “The seattle experience re-visited”. Panel conference Trans. ASAIO 1981; XXVII: 669–670.
Mordasini, R.: Sekundäre Hyperlipoproteinämien bei chronischen Nierenkrankheiten. Verlag Hans Huber Bern—Stuttgart—Wien 1982.
Morrisson, L.M., Bajwa, G.S., Alfin-Slater, R.B., Ershoff, B.H.: Prevention of vascular lesions by chondroitin sulfate a in the coronary artery and aorta of rats induced by a hypervitaminosis D, cholesterol-containing diet. Atherosclerosis 1972; 16: 105–118.
Müller, O.A., van Werder, K.: Rezeptorstörungen in der Endokrinologie- Internist. 1988; 29: 445–454.
Mundy, G.R.: Calcium homeostasis: hypercalcemia and hypocalcemia. Martin Dunitz, London 1989; 149.
Nestel, P.J., Fidge, N.H., Tan M.H.: Increased lipoprotein-remnant formation in chronic renal failure. N. Engl. J. Med. 1982; 307: 329–333.
Oster, P., Müller, T., Schmidt-Gayk, H., Schlierf, G.: Parathyreoid hormone, 25-hyroxyvitamin D and 1,25dihydroxy-vitamin D concentration in elderly patients. Kiin. Wochenschr. 1990; 68: 421–426.
Parrot-Garcia, M., McCarron, D.A.: Calcium and hypertension. Nutrition Rev. 1984; 42: 205–213.
Petersen, M.M., Briggs, R.S., Ashby, M.A., Reid, R.I., Hall, M.R., Wood, P.J., Clayton, B.E.: Parathyreoid hormone and 25-hydrxyvitamin D concentrations in sick and normal elderly people. Brit. Med. J. 1983; 287: 521–523.
Raidt, H.: Untersuchungen zur Atherogenese bei dialysepflichtiger Niereninsuffizienz. Habilitationsschrift; Universität Münster 1987.
Raidt, H., Langer, K., Baumgarten, F. et al.: Hyperparathyreoidism and accelerated arteriosclerosis in uraemic patients. Nephrol. Dial. Transplant. 1987; 2: 418.
Raisz, L.G., Kream, B.E.: Regulation of bone formation. N. Engl. J. Med. 1983; 1: 29–35.
Rambausek, M., Ritz, E., Rascher, W., Kreusser, W., Mann, J.F.E., Kreye, V.A.W., Mehls, O.: Vascular effects of paratyreiod hormone. Adv. Exp. Med. Biol. 1982; 151: 619–632.
Rapoport, J., Aviram, M., Chaimovitz, C., Brook, J.G.: Defective high-density lipoprotein composition in patients on chronic hemodialysis. N. Engl. J. Med. 1978; 299: 1326–1329.
Rasmussen, H.: The calcium messenger system. First part. N. Engl. J. Med. 1986; 314: 1094–1101.
Rasmussen, H.: The calcium messenger system Second Part. N. Engl. J. Med. 1986; 314: 1164–1170.
Reichel, H., Koeffler, H.P., Norman, A.W.: The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 1989; 320: 980–991.
Ritz, E., Augustin, J., Bommer, J., Gnasso, A., Haberbosch, W.: Should hyperlipidemia of renal failure be treated? Kidney Int. 1985; 28, Suppl.: 84–87.
Ross, R.: The pathogenesis of atherosclerosis an update. N. Engl. J. Med. 1986; 314: 488–500.
Rostand, S.G., Kirk, K.A., Rutsky, E.A.: Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int. 1984; 25: 653–659.
Rüegg, J.C.: Calcium in muscle activation. Springer-Verlag Berlin, Heidelberg, New York 1986.
Slatopolsky, E., Martin, K., Hruska, K.: Parathyreoid hormone metabolism and its potential role as a uremic toxin. Am. J. Physiol. 1980; 239: 1–11.
Snyder, S.H., Reynolds, IJ.: Calcium-antagonist drugs: Receptor-interactions that clarify therapeutic effects. N. Engl. J. Med. 1985; 313: 995–1002.
Sokoll, L.J., Morrow, F.D., Quirbach, D.M., Dawson-Hughes, B.: Intact parathyrin in postmenopausal women. Clin. Chem. 1988; 34: 407–410.
Sugiura, M., Inagami, T., Hare, G.M.T., Johns, J.A.: Endothelin action: Inhibition by a proteinkinase C inhibitor and involvement of phosphoinositols. Biochem. Biophys. Res. Commun. 1989; 58: 170–176.
Yanagisawa, M., Inoue, A., Ischikawa, T., Kasuya, Y, Kimura, S., Kumagaye, Nakjima, K., Watanabe, T.X., Sakakibara, S., Goto, K., Masaki, T.: Promary structure, synthesis and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc. Natl. Acad. Sci. USA 1988; 85: 6964–6967.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Westdeutscher Verlag GmbH Opladen
About this chapter
Cite this chapter
Raidt, H., Baumgarten, F., Bauch, HJ., Langer, K., Graefe, U., Hauss, W.H. (1991). Parathormone, Calcium Imbalance and Atherogenesis. In: New Aspects of Metabolism and Behaviour of Mesenchymal Cells during the Pathogenesis of Arteriosclerosis. Abhandlungen der Rheinisch-Westfälischen Akademie der Wissenschaften, vol 87. VS Verlag für Sozialwissenschaften, Wiesbaden. https://doi.org/10.1007/978-3-322-99112-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-322-99112-6_15
Publisher Name: VS Verlag für Sozialwissenschaften, Wiesbaden
Print ISBN: 978-3-322-99114-0
Online ISBN: 978-3-322-99112-6
eBook Packages: Springer Book Archive